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Many thanks to the referees for positive and informative comments. We have modified the manuscript in 
accordance with these comments. 
Reviewer #1.  
1. The title has now been changed to better reflect the content of the paper.  
2. We have amended the Abstract to make unambiguous that we have measured transcripts and not 
protein. 
3. Clinical signs clarified etc. Have explained and referenced IS900 
4. We have included descriptions of results for chemokines/receptors/TCR molecules in the Results. I 
have reformatted Table 1 so that the genes are in strict alphabetic order; it is not possible to arrange 
them in comparison order as there would be some duplication. 
5. The point of the RT-qPCR is validation of the array results – and this it does (section 3.2). The 
rationale for their selection is now explained in section 3.2.  
6. IGFBP6 was represented in the array (see supplementary data Array Express) – but in these 
experiments it did not show differential expression of >1.5 and p≤0.05 in any comparison. As 
referenced in the manuscript we had previously identified it in a preliminary series of experiments 
(Roupaka MSc thesis 2004). 
7. There was strong correlation between array and RT-qPCR (section 3.2) but difference in absolute 
values – this is a common finding and comments/references etc have now been added to the 
Discussion. 
8. MMP9 and TYROBP were not discussed specifically because the purpose of the paper was not to 
cover all genes exhaustively, but to focus on areas of particular interest. If required I can add a 
paragraph to the discussion – but it will not add much.  
Minor comments…. Asterisks explained in Table 1. SDHA/YWHAZ defined. 
 
Revision Note
  
 
 
 
 
 
 
Reviewer #2. 
1. See comment 1 and 2 (Reviewer #1). 
2. Abbreviations now defined. 
3. Further detailed choice of housekeeping genes. The two used were selected from six; including 
ribosomal protein L18, ATPase, GAPDH, β actin as well as SDHA and YWHAZ.  I can list these in 
the text if you wish – but it is not very relevant to the paper. 
4. MIQE guidelines followed for abbreviations. 
5. Statistics further explained, end section 2.5. 
6. References added and clarified. Rather that adding several references for well known facts I have 
included a reference for an informative review (Campbell et al. 2003). 
7. Fig 1 legend better described. 
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Abstract 1 
Paratuberculosis is a chronic enteropathy of ruminants caused by Mycobacterium avium 2 
subspecies paratuberculosis (MAP); infection of sheep results in two disease forms – 3 
paucibacillary (tuberculoid) and multibacillary (lepromatous) associated with the differential 4 
polarization of the immune response. In addition the majority of MAP-infected animals show 5 
no pathology and remain asymptomatic. Microarray and real-time RT-qPCR analyses were 6 
used to compare gene expression in ileum from sheep with the two disease forms and 7 
asymptomatic sheep, to further understand the molecular basis of the pathologies. 8 
Microarrays identified 36 genes with fold-change of >1.5 and P ≤ 0.05 in at least one 9 
comparison; eight candidates were chosen for RT-qPCR validation. Sequence analysis of two 10 
candidates, CXCR4 and IGFBP6, identified three SNPs in each; five were found in all three 11 
forms of disease and showed no significant relationship to pathological type. The IGFBP6 G 12 
3743 
A SNP was not detected in asymptomatic sheep. The data show that the two forms of 13 
disease are associated with distinct molecular profiles highlighted by the differential 14 
expression of chemokine and chemokine receptor transcripts, the protein products of which 15 
might be implicated in the different cell infiltrates of the pathologies. The cells within the 16 
lesions also show evidence of abnormal activation; they express high levels of cytokine 17 
transcripts but have reduced expression levels of transcripts for T cell receptor associated 18 
molecules.  19 
 20 
Keywords:  21 
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1. Introduction 1 
 2 
Mycobacterium avium subspecies paratuberculosis (MAP) is a facultative 3 
intracellular bacterium that primarily infects macrophages and is the causative agent of 4 
paratuberculosis (Johne's disease), a common enteropathy of ruminants. In cattle an extended 5 
preclinical phase is dominated by a type 1 immune response that is followed by progression to 6 
fatal granulomatous disease, which is linked to a switch to a type 2 response and the 7 
production of non-protective IgG1 antibodies (Koets et al., 2002; Kurade et al., 2004). In 8 
sheep both type 1 and type 2 responses give rise to disease states (Clarke, 1997) and there 9 
seems to be no progression from the paucibacillary (type 1 or tuberculoid) to the 10 
multibacillary (type 2 or lepromatous) disease; both are fatal. As with homologous 11 
pathologies in tuberculosis and leprosy, the cytokines that dominate paucibacillary 12 
paratuberculosis are IFN  and IL-12, while IL-10 dominates multibacillary disease (Smeed et 13 
al., 2007). Only a minority of infected (IS900+) sheep progress to disease and the majority 14 
remain asymptomatic with no pathology (Koets et al., 2002; Smeed et al., 2007; de Silva et 15 
al., 2009). 16 
We hypothesize that the polarization of the immune response is critical to the clinical 17 
outcome of paratuberculosis infection. Intestinal tissue damage that results from a type 1 18 
response involves lymphocyte and eosinophil infiltration and is fundamentally different to 19 
that caused by a type 2 response, which leads to epithelioid macrophage infiltration and 20 
dissemination of infection (Smeed et al., 2007). The related disease leprosy also has this 21 
dichotomy of immunology and pathology (Meisner et al., 2001). Furthermore there is a clear 22 
relationship between host genetics and disease type (Fortin et al., 2007); many genes have 23 
been implicated but one that has received much attention is solute carrier family 11 24 
(SLC11A1, NRAMP-1 or Bcg), which is linked to both tuberculosis susceptibility (Vidal et 25 
al., 1993) and discrimination of the two forms of human leprosy (Meisner et al., 2001). 26 
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Resistance to MAP infection in mice is also partly linked to this gene, with animals carrying 1 
the Bcg
r 
allele (e.g. C3H) being refractory to infection (Veazey et al., 1995).  2 
The principal cell populations associated with mycobacterial infection are cells of the 3 
macrophage lineage, a major function of which is the activation of T cells and initiation of the 4 
immune response. Antigen-presenting cell subsets play a crucial role in the polarization of 5 
responses through the differential expression of IL-10 and IL-12 (Pulendran et al., 1999). 6 
They also show differential expression of pattern recognition receptors (PRRs) (Nalubamba et 7 
al., 2008), and differential PRR activation can tailor the immune response (Kapsenberg, 8 
2003). Both TLR2 and CARD15 (NOD2) have been shown to be up-regulated in clinical 9 
paratuberculosis (Nalubamba et al., 2008) and involved in both recognition (Ferwerda et al., 10 
2007) and response (Weiss et al., 2001) to MAP. Indeed, there is growing evidence for 11 
linkage of TLR2 and/or CARD15 mutations and susceptibility to human mycobacterial 12 
diseases (Bochud et al., 2003; Ben-Ali et al., 2004) and bovine MAP infection (Mucha et al., 13 
2009). 14 
To begin to unravel the complex interactions between MAP and the immune system 15 
that gives rise to bovine paratuberculosis, Coussens and colleagues have used bovine 16 
leukocyte microarrays to examine transcript changes in peripheral blood mononuclear cells 17 
(PBMC) (Coussens et al., 2002) and macrophages (Murphy et al., 2006). In addition they 18 
have examined cattle ileal tissue (Aho et al., 2003) in order to understand the mechanisms 19 
that lead to intestinal tissue damage and have identified a number of genes involved in the 20 
immunology and pathogenesis of bovine paratuberculosis (including insulin-like growth 21 
factor binding protein-6 - IGFBP6). Our own studies (Smeed et al., 2007; Nalubamba et al., 22 
2008) have focussed on ovine paratuberculosis because of the defined pathologies in sheep 23 
and exploit an oligonucleotide microarray of ~600 immuno-inflammatory genes (Watkins et 24 
al., 2008) to gain insight into the role of these genes in the development of the different 25 
pathologies. The defined nature of the disease phenotype in sheep facilitates the identification 26 
of genetic markers associated with pathological type, and might also inform studies in cattle.  27 
 28 
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Competitive hybridization of cDNA isolated from the ileum (the site of 1 
paratuberculosis lesions) between the three infected groups was performed to identify changes 2 
to transcript expression associated with each disease group and develop molecular signatures 3 
of each pathological form. Quantitative real-time RT-PCR (RT-qPCR) on selected candidate 4 
genes was used to validate the arrays and the data were analysed to identify and compare 5 
physiological pathways associated with the contrasting pathologies. Data sets gathered from 6 
such experiments provide the potential to follow pathways of immune reactivity as well as 7 
assessing disease states that can then be related to specific gene expression signatures. In 8 
addition, as the epidemiology of these mycobacterial diseases suggests a genetic susceptibility 9 
(Ben-Ali et al., 2004) we investigated this link, by a preliminary single nucleotide 10 
polymorphism (SNP) analysis, between polymorphisms in two of the candidates and 11 
pathological form. 12 
 13 
 14 
 15 
2. Materials and Methods 16 
2.1. Experimental animals and tissues 17 
MAP infected animals presented with clinical Johne’s disease (diagnosed by a 18 
veterinary surgeon: prolonged weight loss, inappetance and depression, and occasional 19 
diarrhoea) were out bred, female sheep (Table S1) of a variety of breeds and ages. All sheep 20 
were euthanized and diagnosis was confirmed by histopathology, Ziehl Neelsen (ZN) staining 21 
and IS900 real-time quantitative PCR  with a sensitivity of 5 genome equivalents (Eishi et al., 22 
2002); sheep of similar ages from the same flocks (Nalubamba et al., 2008), with no signs of 23 
clinical Johne’s disease and positive for IS900 DNA were considered asymptomatic (Smeed 24 
et al., 2007). IS900 is a specific marker for the precise identification
 
of MAP (Green et al., 25 
1989). Animal procedures were performed under a valid Animals (Scientific Procedures) Act 26 
1986 Project Licence.  27 
 28 
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2.2. RNA isolation 1 
 Terminal ileum sections (~0.5 g) were placed in five volumes of RNAlater (Qiagen, 2 
Crawley, UK), incubated overnight at 4ºC and stored at -80ºC. Tissues were homogenized in 3 
guanidine isothiocyanate lysis buffer (RNeasy, Qiagen) and RNA was isolated using the 4 
RNeasy Maxi kit, eluted in 0.8 ml of RNase-free water, precipitated with ethanol and 5 
resuspended in 0.3 ml of RNase-free water. Samples were DNase I digested (Qiagen) and 6 
genomic DNA contamination assessed by GAPDH PCR and a no reverse transcriptase 7 
control. RNA quality was assessed using a RNA 6000 Nano LabChip on the Agilent 2100 8 
bioanalyzer and quantified using a NanoDrop ND-1000 spectrophotometer; all samples had 9 
an RNA integrity number >7; n = 6 for the microarray experiments. 10 
 11 
2.3. Preparation of labelled cDNA and microarray hybridization    12 
cDNA generation and indirect labelling was performed using the Fairplay III 13 
Microarray Labelling Kit (Stratagene, Cambridge, UK) incorporating Cy3 and Cy5 dyes (GE 14 
Healthcare, Amersham, UK); the DyeEx spin 2.0 kit (Qiagen) removed unincorporated dye. 15 
Pre-hybridization and hybridization was carried out using the Pronto!
TM 
Kit (Corning, 16 
Loughborough, UK). This analysis utilized the ruminant immuno-inflammatory gene 17 
universal array (Watkins et al., 2008); 4,824 spots from 596 genes. A 22x22 mm lifterslip 18 
(VWR, VWR, Poole, UK) was then placed over the array and the slide pre-heated to 42ºC. 19 
Equal dye concentrations from two samples (30 pmols each) were mixed, dried and 20 
resuspended in 20 μl cDNA hybridization solution and introduced onto the array. The slides 21 
were incubated for 16 - 20 h at 42ºC with agitation every 7 s, using a SlideBooster (Implen, 22 
Stansted Mountfitchet, UK) and post-hybridization washes of the microarray slides carried 23 
out using the Pronto!TM
 
Kit, using an AdvaWash AW400 slide washer (Implen). The slides 24 
were scanned using a GenePix Autoloader 4200AL, controlled by GenePix Pro v 6.1 25 
(Molecular Devices, Sunnyvale, CA). In total, we performed 18 microarrays. All groups 26 
contained six animals and every sample was analysed on three arrays, with each animal being 27 
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compared with an animal in each of the other groups. The identity of the pairings between 1 
each group was chosen at random. 2 
Protocols of the experimental procedures, methods of analysis and microarray data 3 
are available as supplementary information in the European Bioinformatics Institute’s 4 
ArrayExpress database (www.ebi.ac.uk/arrayexpress). Login to www.ebi.ac.uk/aerep/login  5 
and query for the accession number of the experiment or array design E-TABM-487.  6 
 7 
2.4. Microarray data analysis    8 
Scanned images were aligned to the GenePix Array List (GAL file); background 9 
noise subtracted; spot intensity amplitudes generated and quality data extracted using 10 
BlueFuse v3.3 (BlueGnome, Cambridge, UK). The log2 ratios from the two channels for each 11 
spot were calculated by Bluefuse.  Data generated by Bluefuse were pre-processed using 12 
Limma within BioConductor 2.2 (http://www.bioconductor.org). Normalization was carried 13 
out using a weighted print-tip Loess method. Spots were weighted by a confidence value 14 
provided by BlueFuse. Differentially expressed genes from the different group comparisons 15 
(Table 1) were classified based on biological process using GO annotation. GORetriever, 16 
GOanna and GoSlimViewer (http://www.agbase.msstate.edu) were used to annotate gene 17 
products based on sequence similarity. 18 
 19 
2.5. Real time RT-qPCR validation    20 
RT-qPCR was performed using a Corbett Rotor-Gene™ 3000 (Qiagen). First 21 
strand cDNA synthesis used 0.5 g of total RNA and Oligo(dT) and Superscript™ III RT 22 
(Invitrogen, Paisley, UK), from all RNA samples used for microarrays with a further two 23 
samples from each of the groups (n = 8). Primers for candidate genes were designed (Table 24 
S2) and the amplicons cloned using pGEM-T Easy kit (Promega, Southampton, UK). PCR 25 
conditions were optimized using a standard curve generated from linearized plasmid. All 26 
serial dilutions were generated using a CAS-1200™ Precision Liquid Handling System 27 
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(Qiagen). Succinate dehydrogenase complex, subunit A (SDHA) and tyrosine 3/tryptophan 5 1 
-monooxygenase activation protein, zeta (YWHAZ); were chosen from a group of six using 2 
GeNorm v3.4  (Vandesompele et al., 2002) and NormFinder v 0.953 (Andersen et al., 2004), 3 
as the two most stably expressed genes to normalize the RT-qPCR assays. All reactions were 4 
10 l volumes containing 4 l of cDNA at the optimum dilution (1:20), 5 l 2x FastStart 5 
SYBR Green Master mix (Roche, Lewes, UK) and 0.5 l of each primer at optimum 6 
concentration (Table S2). PCR conditions were: 94ºC for 5 min and 45 cycles of 94ºC for 20 7 
s, 60ºC for 20 s, 72ºC for 20 s, followed by dissociation curve analysis to confirm a single 8 
gene product. Each run assayed one gene and contained all samples in duplicate, a cDNA 9 
standard curve and a non-template control. This was repeated twice using cDNA from two 10 
additional RT reactions, resulting in 6 data points for each gene. The average Cq value for 11 
each sample was calculated and converted into relative quantities, taking account of the gene 12 
specific efficiency of the reaction and multiple reference gene normalization, using qBase 13 
(Hellemans et al., 2007). Statistical analyses were performed on data from individual animals 14 
using Kolmogorov-Smirnov to test for normality of distribution and two-tailed Student’s t-test 15 
for each of the comparisons.  16 
 17 
2.6. PCR and DNA sequencing    18 
DNA was extracted from 250 mg ileum using the Qiagen DNEasy Blood and Tissue 19 
kit or Qbiogene Fast DNA kit and quantified using the Nanodrop ND-1000 spectrometer. Full 20 
length mRNA sequence was obtained for sheep CXCR4 and IGFBP6, and aligned to the 21 
bovine genome to identify the coding regions in the genomic sequence. Primers (Table S3) 22 
were designed to amplify the whole bovine coding region and the intron / exon boundaries 23 
where possible (Fig. S1). Three PCR reactions were performed with each set of primers on 24 
ten animals in each infected group (Table S1). The PCR products from each sample were 25 
mixed, purified, ligated and cloned into the PGEM-T easy. Three independent sequences were 26 
produced for each PCR product and consensus sequences produced using VectorNTI AlignX 27 
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(Invitrogen). Differences between the genomic sequences were considered to be SNPs when 1 
the same change was found consistently in two or more of the consensus sequences. The 2 
distribution of alleles and genotypes was compared between the pathological groups using the 3 
χ2-test. 4 
 5 
3. Results 6 
3.1. Microarray analysis    7 
Of the 596 genes analysed, 36 fulfilled the criteria of fold-change of ≥1.5 and P≤0.05 8 
in at least one comparison (Table 1 and supplementary information). The fold-changes shown 9 
are means of all probes for each gene. Intrinsic variation within replicate spots on single 10 
arrays (technical) and between arrays (biological) was determined. Technical variation was 11 
determined by comparing normalized log2 ratios of the spots printed in triplicate within each 12 
array, for six replicate array experiments of each comparison. The median standard deviation 13 
for the 3 comparisons varied from 0.24 (for multi- verses paucibacillary (M v P) to 0.26 (for 14 
multi- verses asymptomatic (M v A) with a variance of between 0.06 and 0.07 across the three 15 
comparisons. The biological variation was analysed by comparing the log2 ratios (CH1:CH2) 16 
of identical spots between the 6 replicate arrays in each comparison.  The median standard 17 
deviation for each comparison ranged from 0.37 to 0.42, with a variance between 0.14 and 18 
0.18 across all comparisons, demonstrating that within chip variability (technical variation) 19 
was between third and a half of the between chip variation (biological variation).         20 
ITGAL was the only gene significantly affected in all three comparisons (Table 1, 21 
Fig. 1) and two other genes (SELL and TFRC) were up-regulated but P≥0.05. Five genes 22 
were differentially expressed between the two disease groups and the asymptomatic group 23 
(Table 1). Fifteen genes were significantly different in the paucibacillary vs asymptomatic 24 
comparison including a 1.52 fold repression of CCL5 and a 2.25 fold increase in CXCL10. 25 
Twenty three were significantly different in the multibacillary vs asymptomatic comparison 26 
including a 1.64 fold increase in CCL2; 1.54 and 1.82 fold increases in CXCR3 and CXCR4 27 
and 1.59 and 1.67 decreases in CD3E and CD3F. The pauci- vs multibacillary comparison 28 
  10 
identified fifteen affected genes, but only four (C9, CLIC5, ITGAM and MMP7) were unique 1 
to that comparison, as the other comparative data was not significant (<1.5 and p>0.05).  2 
Within the limitations of this focussed microarray, it is clear that the differentially expressed 3 
genes associated with each of the paratuberculosis pathologies were connected with a distinct 4 
range of biological processes (Fig. 2). Both clinical diseases showed changes to genes linked 5 
to responses to biotic stimuli, cell differentiation and signal transduction but only in the 6 
multibacillary form were there changes to genes associated with cell communication. 7 
 8 
3.2. RT-qPCR validation of microarray results    9 
Of the 36 genes found to be differentially expressed in the microarray experiment, 10 
seven candidates were chosen for RT-qPCR validation of the array; CD63, CXCR4, IGF2R, 11 
ITGB2, MMP9, TLR2, and TYROBP; on the basis that they represent different biological 12 
processes (Fig. 2) and were differentially expressed between pauci- and multibacillary 13 
samples. In addition we identified IGFBP6 as it had been highlighted as being differentially 14 
expressed in bovine paratuberculosis (Coussens et al., 2004) and in a preliminary array 15 
analysis (Roupaka, 2004). Table 2 shows the results expressed as relative fold-changes in the 16 
same comparisons as performed in the microarray. The RT-qPCR analyses for seven original 17 
candidate genes validated the results from the microarray experiment with a correlation 18 
coefficient (r) 0.63 – 0.97, mean of 0.87. Comparison (two-tailed Students t test) of 19 
expression levels of all eight candidates between Blackface x Blue du Maine vs other breeds 20 
in the paucibacillary group and Blackface x Blue du Maine vs other breeds in the 21 
asymptomatic group showed that breed had no significant impact (P > 0.8) on the distribution 22 
of the data. Similar comparisons of the 4-5 year old vs the 2-3 year old Blackface sheep in the 23 
multibacillary group also showed that age also had no effect on the data (P > 0.9). 24 
 25 
3.2. Single nucleotide polymorphism (SNP) analysis    26 
Analysis of the consensus CXCR4 sequences revealed the presence of three 27 
synonymous SNPs; in exon 2 a C to T change at position 2080 and a G to A change at 2275 28 
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and in exon 3 a G to A change at 3361; the last was 3’ of the stop codon. Analysis of IGFBP6 1 
sequence also revealed three SNPs – a non-synonymous C to A change at position 12 in exon 2 
1, which changes a histidine to a glutamine; a synonymous G to A change at 2730 in intron 3 3 
and a G to A change at 3743 in exon 4, 3’ of the stop codon at position 3612 (Fig. S1). When 4 
these six SNPs were analysed in relation to infection there was no significant relationship 5 
between any SNP and disease form (Table 3). Each of the three CXCR4 SNPs and two 6 
IGFBP6 SNPs were found in all infected groups. However, IGFBP6 SNP3 (G 3822 A) was 7 
only found in clinically diseased animals, and was absent from the asymptomatic group. The 8 
animals tested were of a variety of breeds and crosses (Table S1) but there was no 9 
discernable, significant relationship between breed and any genotype (χ 2, P ≥ 0.79). 10 
 11 
 12 
4. Discussion 13 
This is the first microarray analysis of ileal gene expression in sheep with clinical 14 
paratuberculosis and directly compares gene expression at the site of infection in each of the 15 
pathologies, and has identified novel pathways involved in MAP pathogenesis. Previous work 16 
on sheep paratuberculosis has shown that the pauci- and multibacillary pathologies are 17 
associated type 1 and type 2 T cell responses respectively, with the differential activation of T 18 
cells (Burrells et al., 1998) and the expression of quite distinct panels of both innate receptors 19 
(Nalubamba et al., 2008) and cytokines (Smeed et al., 2007). Analysis of the data for the 20 
eight candidate genes indicates that it is highly unlikely that these changes are associated with 21 
the breed or age (Table SI). Paratuberculosis is characterized by extensive inflammation and 22 
cellular infiltration of the terminal ileum; paucibacillary disease is associated with 23 
lymphocytes and eosinophils, and multibacillary lesions with epithelioid macrophages 24 
(Smeed et al., 2007). These variations in the cellular composition are reflected in the 25 
differences in gene expression profiles detected by microarray, with 36 genes found to be 26 
differentially expressed (>1.5 fold and P≤0.05) in at least one comparison (Table 1).  The RT-27 
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qPCR data justify our decision to use 1.5 fold (and p ≤ 0.05) as the cut-off point for our 1 
candidate gene selection as they confirmed the array data in relation to the direction of fold 2 
change.  In addition, fold changes of just under 1.5 (but p ≤ 0.05) were shown to be 3 
significantly different by RT-qPCR, e.g. MMP9. RT-qPCR also confirmed the array data, 4 
both quantitatively and qualitatively, when microarray showed no change (>–1.5 to <1.5), e.g. 5 
CD63 in the pauci- vs asymptomatic comparison. The correlation coefficient (r) between 6 
array and RT-qPCR varied between candidate genes (0.63 – 0.97, mean  r = 0.87) and was 7 
similar to that described in other systems (Dallas et al., 2005), but was much lower for genes 8 
with a fold change of <1.5. The magnitude of fold change with RT-qPCR was generally much 9 
higher than with microarray, which is probably due to the different sensitivities of the two 10 
assays (Morey et al., 2006); nevertheless RT-qPCR is the preferred validation method for 11 
microarrays (Dallas et al., 2005).  12 
 13 
Within the limitations of the focussed microarray, it is clear that the differentially 14 
expressed genes associated with each of the pathologies were connected with a distinct range 15 
of biological processes (Fig. 2) probably associated with the different cell infiltrates in the 16 
two disease forms. The multibacillary samples displayed a consistent repression of the several 17 
genes encoding elements of the T cell receptor complex - CD3E, CD3G (and CD3Z with –18 
1.47 fold change and P ≤ 0.05). This might be related to the fact that the principal cells in 19 
multibacillary ileum were infected epithelioid macrophages and not T cells. It is possible that 20 
this reduction in antigen-receptor expression is a result of infection-associated aberrant 21 
activation and may represent a specific bacterial mechanism for the modification of the host 22 
immune response towards the development of disease as is seen in tuberculosis (Smith, 2003). 23 
Related to this were changes to transcripts of the different immunoglobulin molecules. 24 
IGHA1 and IGHM were raised in both disease forms and IGJ was increased in paucibacillary 25 
lesions. In view of the fact that B cell receptor associated genes were not raised in infected 26 
tissues, these increases in immunoglobulin heavy chain transcripts may be a result of greater 27 
numbers of plasma cells rather than mature B cells. This pattern of immunoglobulin heavy 28 
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chain expression does not fit exactly into the Th1/Th2 paradigm, which would predict high 1 
levels of IGHA only in the multibacillary (lepromatous) lesions (Mosmann and Coffman, 2 
1989). 3 
Representatives of the 1 and 2 integrins (ITGA4 and ITGAL) were up-regulated in 4 
the paucibacillary forms. However, their behaviour was less consistent in the multibacillary 5 
form where the β1 integrin ITGA4 is repressed and the β2 integrins ITGAL, ITGAM and 6 
ITGB2 were increased. The four transmembrane domain proteins (e.g. CD63) interact with 7 
integrins and modulate their function; and the high levels of CD63 in multi- relative to 8 
paucibacillary lesions may be indicative of different cell populations associated with those 9 
lesions. The major cellular ligand for the 2 integrins is ICAM1. This, and the lymphocyte 10 
adhesion molecule, SELL (CD62L or L selectin), were high in multibacillary diseased tissues, 11 
which reflects major cellular infiltration and also inflammation, as both are up-regulated by 12 
inflammatory cytokines (Dustin and Springer, 1991).  13 
The stimulus for leukocyte infiltration into lesions is probably different for each 14 
disease form. CCL2 was raised in multibacillary lesions (and 1.65 fold but P ≥ 0.05 in the 15 
pauci- vs asymptomatic comparison) and was probably produced by a variety of cells on 16 
stimulation with pro-inflammatory cytokines and IFN . It is chemotactic for lymphocytes and 17 
monocytes but not eosinophils and its role in inflammation is as an activator of neutrophils 18 
(Campbell et al., 2003). CCL5 is associated with T cell and dendritic cell recruitment, but it 19 
was repressed in the paucibacillary group. CCL5 is a product of activated T cells, but only at 20 
the late stage of activation, and is down-regulated by TGF  and IFN  both of which were 21 
increased in paucibacillary tissues (Smeed et al., 2007). This is additional evidence for the 22 
aberrant activation of T cells in the paratuberculosis lesions. The chemokine CXCL10 is 23 
associated with chemoattraction of type 1 T cells (Campbell et al., 2003) and was 24 
significantly raised in paucibacillary lesions and might explain the T cell infiltration. 25 
However its receptor, CXCR3 was up-regulated in multibacillary tissues, probably due to the 26 
effect of high levels of TGF . The closely related chemokine receptor, CXCR4 is also 27 
  14 
responsive to TGF  and was significantly increased in multibacillary tissues. This is the 1 
receptor for CXCL12 (SDF-1) and one of its major functions is as a chemoattractant for Th2 2 
and regulatory T cells (Campbell et al., 2003).  3 
IGF2R, the receptor for IGF2 and mannose-6-phosphate, was increased in the 4 
multibacillary disease form and plays a role in the activation of TGFβ (Melnick et al., 1998), 5 
a gene previously shown to be up-regulated in these samples (Smeed et al., 2007). IGFBP6 6 
was differentially expressed in sheep paratuberculosis (increased in paucibacillary and 7 
repressed in multibacillary diseased ileum) and it was also up-regulated in cattle PBMC 8 
stimulated by MAP (Coussens et al., 2004). It binds with high affinity to IGF2 and inhibits 9 
many of its functions, including proliferation and differentiation (Kelley et al., 1996).  Its 10 
expression has previously been reported to be stimulated by IL-1  and TNF  but inhibited by 11 
the presence of TGFβ (Martin et al., 1994; Liu et al., 1999), and this might explain the 12 
significantly increased levels of IGFBP6 in paucibacillary lesions. In paucibacillary tissues, 13 
high IGFBP6 levels could play a role in controlling cellular proliferation by inhibiting IGF2 14 
and inducing apoptosis. TLR2 was greatly up-regulated in multibacillary lesions, suggesting 15 
that the TLR2 signalling pathway is important in lepromatous pathogenesis. TLR2 is central 16 
to the immune response to mycobacteria, as knockout mice are more susceptible to infections. 17 
In human leprosy TLR2 is linked to differential pathology, as signalling through the mutated 18 
receptor leads to increased IL-10 production and a type 2 immune response (Kang et al., 19 
2004). Consistent with this are increased levels of IL-10 in multibacillary tissues and raised 20 
IFN  in paucibacillary lesions (Smeed et al., 2007). Multibacillary tissues show high levels of 21 
both CXCR4 and TLR2 and, interestingly, cross-talk between these has been reported in 22 
Porphyromonas gingivalis infection that leads to the undermining of host defence 23 
(Hajishengallis et al., 2008). The data on the linkage between TLR2 and MAP in ruminants is 24 
not clear. Analysis of TLR2 SNPs in sheep paratuberculosis failed to identify any linkage 25 
with pathological form (Nalubamba et al., 2008) although in cattle there was significant 26 
association of a distinct SNP with MAP infection (Mucha et al., 2009).    27 
  15 
Due to their differential expression in multibacillary and paucibacillary sheep, 1 
CXCR4 and IGFBP6 were selected for preliminary SNP analysis and to assess whether these 2 
SNPs were associated with gene expression and pathology. All SNPs except IGFBP6 at 3743 3 
were found in the three infected groups and there was no significant association with any 4 
disease form. The IGFBP6 SNP at 3743 is 3’ to the stop codon and was not found in 5 
asymptomatic sheep; there was no statistically significant association with disease form 6 
possibly because of the small numbers of animals (n=10) in each group.  7 
To summarize, this study identifies novel genes and pathways linked to mycobacterial 8 
pathologies. The two disease forms of sheep paratuberculosis are associated with distinct 9 
molecular profiles highlighted by the differential expression of chemokines, which are 10 
implicated in the different cellular infiltrates of the pathologies and the polarization of the 11 
immune response. Cells within the lesions show evidence of abnormal activation, with high 12 
levels of cytokine transcripts and a reduction in expression levels of transcripts for 13 
lymphocyte receptor molecules. Preliminary analysis could identify no significant link 14 
between CXCR4 and IGFBP6 SNPs and paratuberculosis pathologies.  15 
 16 
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Figure Legends 1 
Fig. 1. Venn diagram showing the relationships between genes differentially expressed in the 2 
ileum of sheep infected with MAP; comparisons between the three infected groups; A, 3 
asymptomatic; M, multibacillary; P, paucibacillary. The figures are the numbers of 4 
differentially expressed genes in the different comparisons with a fold change of ≥1.5 and 5 
P≤0.05. Figures in parentheses are the number of genes with fold change of ≥1.5 but P>0.05. 6 
 7 
Fig. 2.  Distribution of GO annotations of biological processes terms of genes that were 8 
differentially expressed (fold change of ≥1.5 and P≤0.05) in ileum tissue of MAP infected 9 
sheep. (a) Comparison of paucibacillary vs asymptomatic. (b) Comparison of multibacillary 10 
vs asymptomatic. (c) Comparison of multibacillary vs paucibacillary. 11 
 12 
Fig. S1.  Gene structures of bovine CXCR4 and IGFBP6 illustrating the positions of the 13 
cloning fragments and SNPs. 14 
 15 
Table 1   
Mean fold–changes of significantly differentially expressed genes.  
 
NCBI Official Symbol 
(Gene) 
Accession 
Number 
P v A M v A M v P 
ANPEP (CD13) X98240 –2.32 –2.50  
C3 (complement C3) AF038130 1.53 1.75  
C7 (complement C7) AF162274  1.5  
C9 (complement C9) F14494   –1.61 
CFB (complement Factor B) NM_001040526 1.52   
CCL2 (MCP-1) M84602 1.65* 1.64  
CCL5 (RANTES) AJ007043 –1.52   
CD3E Z12969  –1.59  
CD3G X52994  –1.67  
CD63 (LAMP3) AJ012589  1.87 1.62 
CLIC5 AF109199   –1.54 
CXCL10 (IP-10) AB070717 2.25  –1.72* 
CXCR3 (CD183) X95876  1.54  
CXCR4 (CD185) AF399642  1.82 1.9 
ICAM1 (CD54) AF110984 1.45 1.9 1.31 
IGF2R (CD222) AF327649  1.74 1.51 
IGFBP3 AF327651 –1.61 –1.56  
IGHA1 AF024645 1.96 1.85  
IGHM X59994 2.31 1.83  
IGJ (J chain) L20311 1.89  –1.61 
IL-18RAP (CD218b) NM_010553 1.68   
ITGA4 (CD49D) AB055841 1.52  –1.59 
ITGAL (CD11A/LFA-1) BF654844 1.9 3.58 1.95 
ITGAM (CD11B/MAC-1) AW353414   1.51 
ITGB2 (CD18) M81233  2.03 1.95 
MHC-DYA AJ251357 1.67   
MMP7 (matrilysin) AB031323   1.84 
MMP9 (gelatinase B) X78324  1.98 1.76 
pIGR  (secretory component) L04797 1.56   
SELL (CD62L) X62882 1.58* 1.85 1.83* 
SIRPA (CD172A) Y11045 1.41 1.65  
SLC11A1 (NRAMP1) AF005380  1.57 1.63* 
TFRC (CD71) M11507 1.78 2.79 1.81* 
TLR2 (CD282) AF310951  1.52 1.52 
TNFRSF1B (CD120b) NM_001040490              1.62 1.5 
TYROBP (DAP12) AJ419226  1.95 1.68 
Table 1
 A – asymptomatic; M – multibacillary; P – paucibacillary. 
Bold denotes genes selected for validation by qRT–PCR. Changes less than 1.5 fold (and 
P≤0.05) are in italics to show trends in the data.  *Changes not statistically significant, but 
>1.5 fold. The blank cells are fold change <1.5 and P>0.05. 
Table 2  
Relative fold-change of genes analysed by qRT-PCR. 
P v A M v A M v P
CD63 1.1 (0.7)a 3.2 (0.00) 3.0 (0.00)
CXCR4 2.89 (0.05) 6.13 (0.01) 2.12 (0.05)
IGFBP6 1.86 (0.05) -1.37 (0.5) -2.54 (0.02)
IGF2R 2.0 (0.02) 4.2 (0.00) 2.1 (0.00)
ITGB2 2.1 (0.02) 4.3 (0.00) 2.1 (0.00)
MMP9 1.6 (0.02) 14.9 (0.00) 9.3 (0.00)
TLR2 1.6 (0.4) 6.8 (0.00) 4.3 (0.00)
TYROBP 3.1 (0.01) 9.4 (0.00) 3.0 (0.00)
A – asymptomatic; M – multibacillary; P – paucibacillary.
a mean fold change (P value). Bold, P ≤ 0.05.
Table 2
Table 3
Distribution of SNPs
Frequency (10 in each group)      
Genotype Multi Pauci Asympto χ2 P value
CXCR4 
C 2080 T 
2 4 4 0.33
CXCR4
G 2275 A 
2 2 4 0.51
CXCR4
G 3361 A 
4 2 1 0.27
IGFBP-6
C 12 A 
1 1 1 1.00
IGFBP-6
G 2730 A 
4 5 5 0.88
IGFBP-6
G 3743 A 
2 1 0 0.33
Table 3
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1
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Table S1
Pathology, breed and age of sheep
Pathology Breed Age (y)
Paucia Blackface × Bleu du Maine 4.5
Paucia Texel 5.5
Paucia Blackface × Bleu du Maine × Lleyn × Roussin 2.5
Paucia Lleyn × Roussin 3.5
Paucia Blackface × Bleu du Maine 6
Paucia Texel 2.5
Paucib Blackface × Bleu du Maine 4.5
Paucib Blackface 2
Pauci Blackface × Bleu du Maine 4
Pauci Blackface 3.5
Multia Blackface 3
Multia Blackface 4
Multia Blackface 3
Multia Blackface 3
Multia Blackface 5
Multia Blackface 5
Multib Blackface 2
Multib Blackface × Bleu du Maine 4.5
Multi Blackface × Bleu du Maine 4
Multi Blackface 4
Asymptoa Blackface × Bleu du Maine 7
Asymptoa Greyface 4
Asymptoa Texel 1
Asymptoa Blackface 2.5
Asymptoa Greyface 4
Asymptoa Greyface 4
Asymptob Blackface × Bleu du Maine 7
Asymptob Blackface × Bleu du Maine 4.5
Asympto Blackface × Bleu du Maine 3.5
Asympto Blackface 3
a animals used in the microarray experiments
b additional animals used in qRT-PCR experiments
Table S1
Table S2   
Primer sequences for qRT-PCR  
 
 
 
 
 
 
 
 
 
Gene 
Accession no 
Primers 
Annealing  
Temp C 
Product 
size (bp) 
Primer 
conc (nM) 
CD63  
BC151412.1 
F - GGGCTGTGTGGAGAAGATTG  
R- GATGAGGGGGCTGAAGAGAC 
61 178 
F: 700 
R: 1000 
CXCR4 
AF399642 
F - ACCTCCTGTTTGTCCTACG  
R - AATGTCCACCTCGCTTGC 
62 163 
F: 500 
R: 500 
IGFBP-6 
NM_001134308 
F - AAGGAGAGTAAGCCCCAAGC  
R - CGGGAAGGAGTGGTAGAGGT 
60 95 
F: 500 
R: 500 
ITGB2 
NM_001009485 
F - CTCACCGACAACTCCAAACA  
R - AAAGTGGAACCCATCGTCTG 
57 180 
F: 400 
R: 400 
IGF2R          
AF353513 
F - GACGACCTGAAGACCCTGAA  
R - GCAAATGAAGCGGATGATG 
60 150 
F: 500 
R: 500 
MMP9  
X78324 
F - GAGGGTAAGGTGCTGCTGTTC  
R - AAGATGTCGTGCGTGCTAATG 
62 133 
F: 400 
R: 500 
TLR2  
AM183218 
F - GCACTTCAACCCTCCCTTTTA  
R - TCTCCGAAAGCACAAAGATG 
57 125 
F: 500 
R: 500 
TYROBP 
AJ419228.1 
F - GACCTGATGCTGACCCTCC  
R - CTGTCTCCGTGATGTGCTGT 
56 112 
F: 400 
R: 500 
SDHA 
NM_174178 
F - ACCTGATGCTTTGTGCTCTGC  
R - CCTGGATGGGCTTGGAGTAA 
62 126 
F: 500 
R: 500 
YWHAZ 
BC102382 
F - TGTAGGAGCCCGTAGGTCATC  
R - TCTCTCTGTATTCTCGAGCCAT 
58 101 
F: 500 
R: 500 
Table S2
Table S3.  Primer sets used to sequence CXCR4 and IGFBP-6
Gene
Accession Number
Primer Sequence Size (bp) Start positiona
CXCR4 F1 - GAAACTTCAGTGTGTTGGCT 186 -96
NM_174301 R1 - CCACTCAGAGAGGCGGTTG
F2 - ATTCCCTTGCCTGTTTTTCA 561 2035
R2 - GTACCTCTCATCCACCTCCTTG
F3 - GTCTGGCTACCTGCTGTCCT 536 2521
R3 - GAATGTCCACCTCGCTTGC
F4 - CCCATCCTCTATGCCTTCCT 398 2938
R4 - CGGTCCTACAATGACACACAGC
F5 - GAATCTTCAAGTTTTCACTCCAG 593 3076
R5 - GCCAAAGGAATGCCAATAG
IGFBP-6 F1 - CTGGGAAGGGAGGAGGTAGAG 456 -227
NM_001040495 R1 - CGCAGTTGGGAGTGTAGACC
F2 - CTTGCGGCTGTAGGAGAGAATC 255 2291
R2 - CAGGACTGGGATGGGAGACTT
F3 - AAGTCTCCCATCCCAGTCCT 296 2525
R3 - GAAGGGCAGCGTCTCATTTA
F4 - GAGGTCCTTGCTGGTGTG 306 3514
R4 - GAACACAGAGACATAAACCAGAG
a numbered relative to start codon.
Table S3
